Page 1 | Search Results | Blood Advances | American Society of Hematology

1-20 of 444

Sort by

Sort Order Select

Journal Articles

Outcomes after transition from ibrutinib to zanubrutinib in patients with Waldenström macroglobulinemia from the ASPEN study

Ramón García-Sanz, Roger G. Owen, Wojciech Jurczak, Meletios A. Dimopoulos, Helen McCarthy, Gavin Cull, Stephen S. Opat, Jorge J. Castillo, Marie José Kersten, Björn E. Wahlin, Sebastian Grosicki, Radha Prathikanti, Tian Tian, Heather Allewelt, Aileen Cleary Cohen, Constantine S. Tam

Blood Adv (2025) 9 (24): 6538–6546.

https://doi.org/10.1182/bloodadvances.2024015596

Published: 2025

Journal Articles

Challenges and opportunities for improvement in the practical management of adults with acute lymphoblastic leukemia

Ryan D. Cassaday

Blood Adv (2025) 9 (24): 6345–6353.

https://doi.org/10.1182/bloodadvances.2025017584

Published: 2025

Journal Articles

Emicizumab in infants: not just cost-effective but mandatory

Guy Young

Blood Adv (2025) 9 (24): 6354–6355.

https://doi.org/10.1182/bloodadvances.2025017871

Published: 2025

Journal Articles

Utilization Patterns of Hematology Consultation in the Intensive Care Unit: An 11-year Single Center Experience

Cecily Allen, Michael B Streiff, Rakhi P. Naik, Nitin Seam, Sameer Kadri, Alfred I Lee, Melissa Knauert, George Goshua

Blood Adv bloodadvances.2025018327.

https://doi.org/10.1182/bloodadvances.2025018327

Published: 2025

Includes: Supplemental data

Journal Articles

Foundations of Systems-Based Hematology: Thematic Analysis of Expert Interviews to Guide Curriculums and Promote Growth

Richard C. Godby, Jacob C. Cogan, Adam Cuker, David A Garcia, Ming Y Lim, Camila Masias, Jori Ellen May, Colleen T. Morton, Jordan K Schaefer, Surbhi Shah, Marc Zumberg, Ariela L. Marshall

Blood Adv bloodadvances.2025018748.

https://doi.org/10.1182/bloodadvances.2025018748

Published: 2025

Journal Articles

ASH's Commitment to SCD: Building on 10 Years of Progress

Alexander Boucher, Oladipo Bankole Cole, Payal Chandarana Desai, Chancellor Donald, Titilope A Fasipe, Charles T. Quinn, Julie Kennedy Lesch, Alexis A. Thompson

Blood Adv bloodadvances.2025017964.

https://doi.org/10.1182/bloodadvances.2025017964

Published: 2025

Journal Articles

Increasing ketamine administration in children's hospitals for youth with sickle cell disease

Ashley Jenkins, Erin Hendry, Alexandra Power-Hays, Marin Valentino, Matthew Hall, Kathryn E. Kyler, James W Antoon, Sonya Tang Girdwood, Jennifer Goldman, Armand Morel, Timothy Savage, Lucas Orth, Natasha M. Archer

Blood Adv bloodadvances.2025016826.

https://doi.org/10.1182/bloodadvances.2025016826

Published: 2025

Includes: Supplemental data

Journal Articles

Acupressure alleviates pain and clinical symptoms in patients with sickle cell disease

Lina Houran, Andrew Q. Pucka, Mio Jiang, Ziyue Liu, Andrew R. W. O’Brien, Steven E. Harte, Richard E. Harris, Zahra Pakbaz, Ying Wang

Blood Adv (2025) 9 (23): 6126–6129.

https://doi.org/10.1182/bloodadvances.2025016995

Published: 2025

Includes: Supplemental data

Journal Articles

Hairy Cell Leukemia: a chronic B-lymphoma with unique clinicopathological features and unresolved molecular mechanisms

Ge Zhang, Jiancheng Hu

Blood Adv bloodadvances.2025017165.

https://doi.org/10.1182/bloodadvances.2025017165

Published: 2025

Journal Articles

Identification of 4 autophagy-related genetic variants as risk factors for chronic lymphocytic leukemia

Antonio José Cabrera-Serrano, José Manuel Sánchez-Maldonado, Juan José Rodríguez-Sevilla, Fernando Jesús Reyes-Zurita, Rosa Collado, Anna Puiggros, Elena Cornejo-Calvo, Paloma García-Martín, Rob Ter Horst, Yolanda Benavente, Andrés Jerez, Stefano Landi, Blanca Espinet, Rossana Maffei, Miguel Ángel López-Nevot, Silvia Ramos-Campoy, Carmen González-Olmedo, Tzu-Hua Chen-Liang, Víctor Moreno, Fatin Jannus, Rafael Marcos-Gragera, María Carretero-Fernández, Belém Sampaio-Marques, Irene Gámez, María García-Álvarez, Nicola J. Camp, Trinidad Dierssen-Sotos, Joanna Kamaso, Eva María Pérez, Aaron D. Norman, Mario Luppi, Yang Li, Miguel Alcoceba, Daniele Campa, Silvia de San José, Roberto Marasca, Paula Ludovico, Alyssa Clay-Gilmour, Federico Canzian, Marian Ibañez, Mihai G. Netea, James McKay, Delphine Casabonne, Sonja I. Berndt, Susan L. Slager, Juan Sainz

Blood Adv (2025) 9 (23): 6076–6089.

https://doi.org/10.1182/bloodadvances.2025017345

Published: 2025

Includes: Supplemental data

Journal Articles

Cardiovascular degeneration in Erdheim-Chester disease: prevalence, burden, and outcomes

Blood Adv (2025) 9 (23): 5988–6000.

https://doi.org/10.1182/bloodadvances.2025016608

Published: 2025

Includes: Supplemental data

Journal Articles

Biological parenthood rates among men with sickle cell disease

Anyssa N. Young, Sarah R. Hayford, Sapuni S. Chandrasena, Sara Conroy, Tanvi P. Karkare, Barbara L. Kroner, Allison King, Robert M. Cronin, Luca Badolato, Leena Nahata, Susan E. Creary

Blood Adv (2025) 9 (23): 6059–6062.

https://doi.org/10.1182/bloodadvances.2025017458

Published: 2025

Journal Articles

Association of PET4 response with outcomes of BV-CHP vs CHOP in the ECHELON-2 trial in CD30 + peripheral T-cell lymphoma

Blood Adv (2025) 9 (23): 5976–5987.

https://doi.org/10.1182/bloodadvances.2024015282

Published: 2025

Includes: Supplemental data

Journal Articles

National landscape of pediatric and adult inpatient sickle cell disease care

Ashley Jenkins, Spoorthy Vangala, Matthew McIntosh, Robert LeGros, Sophie Lanzkron, Kevin Fiscella

Blood Adv bloodadvances.2025018089.

https://doi.org/10.1182/bloodadvances.2025018089

Published: 2025

Includes: Supplemental data

Journal Articles

Neighborhood socioeconomic status and overall survival among children with acute lymphoblastic leukemia

Anna L. Hoppmann, Deborah M. Hurley, Stuart Cramer, Monique J. Brown, Rahul Ghosal, Anthony J. Alberg, Smita Bhatia

Blood Adv (2025) 9 (22): 5861–5869.

https://doi.org/10.1182/bloodadvances.2025017044

Published: 2025

Includes: Supplemental data

Journal Articles

An AI model classifies risks of early relapse post–CAR T-cell therapy in a multicenter real-world population with DLBCL

Michelle Wang, Krishna V. Komanduri, Debajyoti Datta, Ayan Patel, Barbee Whitaker, Artur Belov, Benjamin Rubin, Rohit Vashist, Rosa Rodriguez-Monguio, Pelin Cinar, Steven Anderson, Atul J. Butte

Blood Adv (2025) 9 (22): 5837–5852.

https://doi.org/10.1182/bloodadvances.2025016375

Published: 2025

Includes: Supplemental data

Journal Articles

Role of race and ethnicity in survival among children/young adults with relapsed ALL: a Children’s Oncology Group report

Blood Adv (2025) 9 (22): 5738–5751.

https://doi.org/10.1182/bloodadvances.2025016670

Published: 2025

Includes: Supplemental data

Journal Articles

Beyond the CAR-T horizon in mantle cell lymphoma

Thomas E. Lew, John F. Seymour

Blood Adv (2025) 9 (21): 5651–5653.

https://doi.org/10.1182/bloodadvances.2025017583

Published: 2025

Journal Articles

Treatment and outcomes of progression of disease post–CAR T-cell therapy in mantle cell lymphoma: a multicenter analysis

Blood Adv (2025) 9 (21): 5654–5662.

https://doi.org/10.1182/bloodadvances.2025016315

Published: 2025

Includes: Supplemental data

Journal Articles

KDIGO-defined kidney dysfunction predicts long-term outcomes in a multicenter cohort of adults with sickle cell disease

Xu Zhang, Michael R. DeBaun, Kristin Wuichet, Rima Zahr, Zalaya Ivy, Mitchell J. Weiss, Alex G. Bick, Victor R. Gordeuk, Santosh L. Saraf

Blood Adv (2025) 9 (21): 5610–5615.

https://doi.org/10.1182/bloodadvances.2025017204

Published: 2025

Includes: Supplemental data

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Outcomes after transition from ibrutinib to zanubrutinib in patients with Waldenström macroglobulinemia from the ASPEN study

Challenges and opportunities for improvement in the practical management of adults with acute lymphoblastic leukemia

Emicizumab in infants: not just cost-effective but mandatory

Utilization Patterns of Hematology Consultation in the Intensive Care Unit: An 11-year Single Center Experience

Foundations of Systems-Based Hematology: Thematic Analysis of Expert Interviews to Guide Curriculums and Promote Growth

ASH's Commitment to SCD: Building on 10 Years of Progress

Increasing ketamine administration in children's hospitals for youth with sickle cell disease

Acupressure alleviates pain and clinical symptoms in patients with sickle cell disease

Hairy Cell Leukemia: a chronic B-lymphoma with unique clinicopathological features and unresolved molecular mechanisms

Identification of 4 autophagy-related genetic variants as risk factors for chronic lymphocytic leukemia

Cardiovascular degeneration in Erdheim-Chester disease: prevalence, burden, and outcomes

Biological parenthood rates among men with sickle cell disease

Association of PET4 response with outcomes of BV-CHP vs CHOP in the ECHELON-2 trial in CD30 + peripheral T-cell lymphoma

National landscape of pediatric and adult inpatient sickle cell disease care

Neighborhood socioeconomic status and overall survival among children with acute lymphoblastic leukemia

An AI model classifies risks of early relapse post–CAR T-cell therapy in a multicenter real-world population with DLBCL

Role of race and ethnicity in survival among children/young adults with relapsed ALL: a Children’s Oncology Group report

Beyond the CAR-T horizon in mantle cell lymphoma

Treatment and outcomes of progression of disease post–CAR T-cell therapy in mantle cell lymphoma: a multicenter analysis

KDIGO-defined kidney dysfunction predicts long-term outcomes in a multicenter cohort of adults with sickle cell disease

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only